Show all postsFiltered by tag: Competition Law

Commissioner Requires Remedies in Minority Interest Transaction

On November 1, 2004, the Competition Bureau (the “Bureau”) reached a Consent Agreement (the “Agreement”) from La Coop fédérée (“LCF”) and Groupe BMR (“BMR”) in connection with LCF’s acquisition of a minority interest in BMR. The Agreement requires that (i) certain franchisees in four local markets in the province of Quebec find new banner under which to operate; and (ii) that LCF and BMR continue supplying the stores on competitive terms until either a new franchisor is found or the end of 2014.

Read Full Article
Commissioner Obtains Significant Divestitures in Sobeys/Safeway Deal

The Competition Bureau announced yesterday that it had entered into a Consent Agreement (the “Agreement”) with Sobeys Inc. (“Sobeys”) regarding its acquisition of Canada Safeway Limited (“Safeway”). The Agreement requires the divestiture of 23 stores in Manitoba, Saskatchewan, Alberta, and British Columbia.

Read Full Article
2013 Throne Speech: Possible Amendments to Competition Act to Address Cross-Border Price Differences

Yesterday’s Speech from the Throne indicated that consumer protection will be an important part of the Canadian government’s legislative and political agenda for the remainder of its current term of office. Although the speech mentioned several priority areas, there was a clear focus on taking steps to reduce the prices paid by Canadians across a range of industries.

Read Full Article
Cineplex Changes Deal to Get Bureau Approval

Yesterday, the Competition Bureau (the “Bureau”) announced that had issued a No Action Letter (“NAL”) in connection with Cineplex Inc.’s acquisition of 22 movie theatres from Empire Theatres Ltd. The Bureau’s press release also indicated that, during the course of the review, the parties revised their transaction to address concerns raised by Bureau staff.

Read Full Article
Competition Bureau Provides Useful Update to Immunity and Leniency FAQs

The Competition Bureau provided useful guidance to firms regarding its immunity and leniency programs in the form of revised “frequently asked questions: (“FAQs”) that were released today.  The revised FAQs highlight several substantive and procedurals changes to these programs.

Read Full Article

Subscribe & Visit

Subscribe to our Mailings Subscribe to our Mailings

Subscribe to our RSS feed Subscribe to our RSS feed

Find out more about Cassels Brock and the Competition, Antitrust & Foreign Investment Group

Visit Us